Taysha Gene Therapies (TSHA) Earnings Date & Reports
A.I. Advisor
published Earnings
TSHA is expected to report earnings to fall 3.67% to -8 cents per share on November 13
Q3'24
Est.
$-0.09
Q2'24
Beat
by $0.07
Q1'24
Beat
by $0.01
Q4'23
Est.
$0.26
Q3'23
Missed
by $0.76
The last earnings report on August 12 showed earnings per share of -9 cents, beating the estimate of -15 cents. With 1.41M shares outstanding, the current market capitalization sits at 424.23M.